" class="no-js "lang="en-US"> WHO Archives - Medtech Alert
Wednesday, December 06, 2023

Sort by:


Top Post

Experimental Cancer Drug May Slow Inflammation Linked to Heart Disease

An experimental drug already tested as a potential treatment for cancer, lung, and Alzheimer’s disease […]

WHO launching Polio Eradication Campaign in Pakistan using PharmaJet Precision Delivery System

PharmaJet®, a company engineering precision delivery systems that overcome the challenges of vaccine delivery, has […]

The World Health Organisation chooses British air purification company, MedicAir, to tackle ‘invisible threat’ in hospitals

British air purification company, MedicAir, has beaten international firms to be awarded a year-long contract by […]

WHO Recommends Groundbreaking Malaria Vaccine for Children at Risk

The World Health Organization (WHO) is recommending widespread use of the RTS,S/AS01 (RTS,S) malaria vaccine […]

WHO/Europe Launches New Monitoring Tool, Tracking Rates of COVID-19 in UEFA Euro 2020 Host Cities

With the UEFA European Football Championships being played in cities across the WHO European Region, […]

WHO and ECDC Launch Indicator Framework to Evaluate Public Health Effectiveness of Digital Proximity Tracing Solutions

The European Centre for Disease Prevention and Control (ECDC) together with WHO, through its headquarters […]

Breakthrough WHO Initiative Launched in Europe to Engage and Empower CSOs in Health Emergency Responses

Throughout the pandemic, civil society organizations (CSOs) have been crucial partners in reducing the impacts […]

Pan-European Master Plan: Promoting Cycling Can Save Lives and Advance Health

On World Bicycle Day, celebrated on 3 June, WHO highlights a new master plan that […]

Johnson & Johnson Joins World Health Organization in Efforts to Prevent Spread of Ebola in West Africa

Johnson & Johnson (NYSE: JNJ) (the Company) today announced the World Health Organization (WHO) and […]

WHO Supports Greece in Building a National Health System for the 21st Century

During his visit to Greece last week, WHO’s Regional Director for Europe, Dr Hans Henri […]

  1. Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
  2. Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
  3. DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
  4. Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
  5. Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more